The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk


Por: Deming, Y, Filipello, F, Cignarella, F, Cantoni, C, Hsu, S, Mikesell, R, Li, ZR, Del-Aguila, JL, Dube, U, Farias, FG, Bradley, J, Budde, J, Ibanez, L, Fernandez, MV, Blennow, K, Zetterberg, H, Heslegrave, A, Johansson, PM, Svensson, J, Nellgard, B, Lleo, A, Alcolea, D, Clarimon, J, Rami, L, Molinuevo, JL, Suarez-Calvet, M, Morenas-Rodriguez, E, Kleinberger, G, Ewers, M, Harari, O, Haass, C, Brett, TJ, Benitez, BA, Karch, CM, Piccio, L, Cruchaga, C

Publicada: 14 ago 2019
Resumen:
Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) has been associated with Alzheimer's disease (AD). TREM2 plays a critical role in microglial activation, survival, and phagocytosis; however, the pathophysiological role of sTREM2 in AD is not well understood. Understanding the role of sTREM2 in AD may reveal new pathological mechanisms and lead to the identification of therapeutic targets. We performed a genome-wide association study (GWAS) to identify genetic modifiers of CSF sTREM2 obtained from the Alzheimer's Disease Neuroimaging Initiative. Common variants in the membrane-spanning 4-domains subfamily A (MS4A) gene region were associated with CSF sTREM2 concentrations (rs1582763; P = 1.15 x 10(-15)); this was replicated in independent datasets. The variants associated with increased CSF sTREM2 concentrations were associated with reduced AD risk and delayed age at onset of disease. The single-nucleotide polymorphism rs1582763 modified expression of the MS4A4A and MS4A6A genes in multiple tissues, suggesting that one or both of these genes are important for modulating sTREM2 production. Using human macrophages as a proxy for microglia, we found that MS4A4A and TREM2 colocalized on lipid rafts at the plasma membrane, that sTREM2 increased with MS4A4A overexpression, and that silencing of MS4A4A reduced sTREM2 production. These genetic, molecular, and cellular findings suggest that MS4A4A modulates sTREM2. These findings also provide a mechanistic explanation for the original GWAS signal in the MS4A locus for AD risk and indicate that TREM2 may be involved in AD pathogenesis not only in TREM2 risk-variant carriers but also in those with sporadic disease.

Filiaciones:
Deming, Y:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

 Univ Wisconsin, Sch Med & Publ Hlth, Alzheimers Dis Res Ctr, Madison, WI 53792 USA

Filipello, F:
 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

Cignarella, F:
 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

Cantoni, C:
 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

Hsu, S:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Li, ZR:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Del-Aguila, JL:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Dube, U:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Farias, FG:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Bradley, J:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Budde, J:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Ibanez, L:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Fernandez, MV:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

Blennow, K:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

 Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden

Zetterberg, H:
 Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden

 UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England

Heslegrave, A:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

 UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England

 UCL, UK Dementia Res Inst, London, England

Johansson, PM:
 Lund Univ, Dept Clin Sci Helsingborg, Lund, Sweden

Svensson, J:
 Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden

Nellgard, B:
 Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Dept Anesthesiol,Sahlgrenska Univ Hosp,Inst Med, Gothenburg, Sweden

Lleo, A:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, IIB Sant Pau, Barcelona, Spain

 Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain

Alcolea, D:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, IIB Sant Pau, Barcelona, Spain

 Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain

Clarimon, J:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, IIB Sant Pau, Barcelona, Spain

 Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain

Rami, L:
 ICN Hosp Clin, Neurol Serv, IDIBAPS, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain

Molinuevo, JL:
 ICN Hosp Clin, Neurol Serv, IDIBAPS, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain

 Pasqual Maragall Fdn, BarcelonaBeta Brain Res Ctr, Barcelona, Spain

Suarez-Calvet, M:
 Pasqual Maragall Fdn, BarcelonaBeta Brain Res Ctr, Barcelona, Spain

 Ludwig Maximilians Univ Munchen, Biochem, Biomed Ctr BMC, Munich, Germany

 German Ctr Neurodegenerat Dis DZNE, Munich, Germany

Morenas-Rodriguez, E:
 Ludwig Maximilians Univ Munchen, Biochem, Biomed Ctr BMC, Munich, Germany

 Munich Cluster Syst Neurol SyNergy, Munich, Germany

Kleinberger, G:
 Ludwig Maximilians Univ Munchen, Biochem, Biomed Ctr BMC, Munich, Germany

 Munich Cluster Syst Neurol SyNergy, Munich, Germany

 ISAR Biosci GmbH, D-2152 Planegg, Germany

Ewers, M:
 LMU, Univ Hosp, Inst Stroke & Dementia Res, Munich, Germany

Harari, O:
 Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

 Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63110 USA

Haass, C:
 German Ctr Neurodegenerat Dis DZNE, Munich, Germany

 Munich Cluster Syst Neurol SyNergy, Munich, Germany

 Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Chair Metab Biochem, D-81377 Munich, Germany

Brett, TJ:
 Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA

Benitez, BA:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

 Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

 Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63110 USA

Karch, CM:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

 Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

 Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63110 USA

Piccio, L:
 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

 Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

 Univ Sydney, Brain & Mind Ctr, Sydney, NSW 2050, Australia

Cruchaga, C:
 Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

 Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

 Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63110 USA
ISSN: 19466234





Science Translational Medicine
Editorial
AMER ASSOC ADVANCEMENT SCIENCE, 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 11 Número: 505
Páginas:
WOS Id: 000481594700001
ID de PubMed: 31413141
imagen Bronze, Green Accepted

MÉTRICAS